Negative pressure wound therapy Negative pressure wound therapy with instillation Open abdomen a b s t r a c t
Introduction
Despite numerous advances in recent years, severe abdominal sepsis (organ failure associated with infection) remains a serious, life-threatening condition with a high mortality rate. Because of breakthroughs in trauma care that require damage control surgery, the use open abdomen (OA) management has increased in scope and complexity.
In non-coronary ICU's, severe sepsis (SS) is considered the main cause of death. In the USA alone, 900,000 cases of SS are diagnosed every year and it causes 210,000 deaths every year. In Europe, the number of deaths per year is 150,000 [1, 2] .
Peritonitis remains the main cause of developing SS, and up to 11% of patients admitted to the surgical ICU progress to this state due to a previous intra-abdominal infection [3] . Currently, mortality rates for intra-abdominal sepsis ranges between 30% and 40% [4, 5] .
During the past two decades, there has been a paradigm shift toward management of patients with severe abdominal sepsis by OA as a viable alternative to the previously used scheduled repeat laparotomy or continuous peritoneal lavage [6] , as to deal with or prevent recurrent infection. In addition, it is well established that the visceral or retroperitoneal edema secondary to shock and reperfusion, may increase intra-abdominal pressure to dangerous levels, leading intra-abdominal hypertension and organ dysfunction [7] . Patients with this constellation of symptoms must have their abdomens left temporarily open to allow for visceral and renal perfusion as well as adequate pulmonary function.
Negative pressure wound therapy (NPWT) is one of a variety of techniques used to manage the OA. NPWT was initially introduced in 1996 [8] , with the intention of treating chronic soft tissue wounds. Later, it found its way into the treatment options of open abdomen. NPWT with Instillation (NPWT-I) has become a variant of this method. Although this technique was not intended for treatment of open abdomen, its potential as a new therapeutic tool, incited us to use it in patient with a septic open abdomen, and we have continued utilizing this technique thereafter.
In this report, we describe our use of negative pressure wound therapy as delivered by V.A.C.
® Therapy (KCI USA, Inc., San Antonio, TX) in addition to timed, automated instillation of saline in the management of patients with SS.
Overview
Historically, the OA was treated with simpler approaches such as "Bogota bag" [9] , Wittmann Patch [10] and Barker's vaccum Pack [11] , which yielded a variety of complications [12] such as marked adhesion formation, development of enteric fistula, non-quantifiable loss of fluids, evisceration, hemorrhage, contamination of the abdominal cavity surgical wound (especially when in proximity to stomas), spread of bacteria into the ICU and ward environment, and a high rate of subsequent ventral hernias. Different methods of temporary abdominal closure (TAC) have been developed to protect the temporary open abdomen and decrease complications [12, 13] .
NPWT resulted in greater rates of fascia closure [14, 15] obviating the need for subsequent hernia repair in many patients [16] . The utility of this technique is not limited to the early postoperative period, but can be successful in for up to 3-4 weeks after the initial operation [17] . Recent large scale studies have reinforced the benefits of NPWT as compared to other TAC methods [18] , and it's early application has been showed to be beneficial [17] .
Peritoneal negative pressure therapy (PNPT) decreases systemic inflammation and organ damage [19] . PNPT served to evacuate a significantly greater volume of ascites than passive drainage. Systemic inflammation as measured by serum levels of TNF-I, IL-1 and IL-6, was significantly reduced in the PNPT group and was associated with significant improvement in histology of the intestine, lung, kidney, and liver [20] . Efficacy was attributed in part to an attenuation of peritoneal inflammation by the removal of cytokines and other biochemical mediators in the ascitic fluid [19] . Interruption of peritoneal hemolymphodynamics via controlled vacuum aspiration appears to decrease entry of inflammatory mediators into the blood stream, thereby possibly limiting systemic inflammation [21] . The clinical implication of these studies was that because sepsis/trauma results in an inflammatory ascites that may perpetuate organ injury; removal of the ascites can break the cycle and decrease organ damage via source control [19] .
The primary goal of TAC is to create a tension-free closure of the abdomen without increasing intra-abdominal pressure. Attempting primary fascia closure under tension in patients with extensive abdominal wall and intra-abdominal organ edema, is associated with an increased incidence of multiple organ failure (MOF), necrotizing abdominal wall infections, and mortality [7] . The optimal method of TAC should contain and protect the contents of the peritoneal cavity from external contamination and injury, preserve fascia; minimize desiccation and damage to viscera, remove and quantify third space fluid; prevent loss of domain, lower bacterial count, inflammatory response, keep patient's abdominal wall skin dry and intact; preserve the integrity of the abdominal wall, be simple to perform and maintain, provide ease of reentry and have minimal adverse physiologic effects [13, 22, 23] . Various TAC methods have been subject to multiple studies, and their advantages and disadvantages are known [24] , but are too numerous to cite. Although no prospective randomized studies are available to compare effectiveness of various TAC techniques as compared to NPWT-I, some evidence exists that shows a beneficial effect of this technique in the management of complex abdominal pathology [25] . [24] , patients with an APACHE score of 12 or greater at admission with a diagnosis of abdominal sepsis, with contamination or with secondary generalized peritonitis. All other patients that required management with an open abdomen who did not meet the previously expressed criteria were excluded from our study.
Methods
The scope of our study involves only the use of NPWT-I in regards to the management of intra-abdominal sepsis, other considerations such as abdominal closure, management of abdominal compartment syndrome and other associated conditions are not fully address and are not the main consideration of this paper.
Our study group consisted of 20 males and 28 females, with ages between 22 and 76 years, in whom the infectious source was found but not controlled during the first intervention and management via OA and abdominal cavity washout for residual contamination was scheduled. All patients selected received NPWT-I. The procedure was performed by applying a sterile abdominal dressing, which consists of a fenestrated soft plastic non-adherent layer with enclosed central foam, which is placed on the surface of the viscera. Then, two layers of V.A.C. GranuFoam ® dressings are applied over the plastic layer, the first layer in direct contact with the non-adherent plastic and located inside the abdominal cavity under the edges of the incision and the second, is placed directly in the abdominal incision filing the exact space of the wound opening (Fig. 1) . Finally, a transparent adhesive is placed over the GranuFoam ® and the wound to seal the abdominal cavity. A 1-inch diameter orifice is cut off the plastic seal on the lower or caudal area of the wound to connect a Sensa T.R.A.C. ® adhesive pad, which will serve as the outflow tubing, that will be later connected from the dressing to the canister in the negative pressure device. Before the final connection is made, test of the integrity (seal) of the vacuum system must be performed by connecting a sterile suction tube to the wound system, and thus guaranteeing that no leaks are present. Finally, a second 1-inch dressing is placed over the wound to adhere the instillation tubing, which is later connected to a saline The parameters are divided in a three step cycle, the first part involves instillation, followed by a dwell period, and finalized by vacuum aspiration.
The instillation cycle is programmed for 120 s, using 0.9% sodium chloride solution, for an estimate of approximately 40-50 mL every cycle. The volume of instillation was obtained from previous experiences in our Hospital, in which larger volumes of saline solution were used, without yielding better results. Temperature of the fluids should be maintained at a range of 21-36 • C. During instillation, the negative pressure switches off automatically. Instillation was followed by a 5-min dwell time, and then NPWT is resumed for 30 min. During the final step, a continuous vacuum set at a range of 100-125 mm Hg is used to retrieve the instilled solution along with any abdominal fluid. Approximately 37 cycles are delivered per day, depending on the time required to service the machine between replacement of canisters or saline bags, with a total volume of instillation of approximately 1.8 L per day. Dressing changes were performed every 48-72 h in all cases with the exception of faulty or clogged sponge systems when dressing changes where performed immediately upon detection.
All dressing changes were performed in a sterile fashion in the operating room. All patients were monitored with daily blood work, which consisted of a complete metabolic panel and complete blood count. Bladder pressure was monitored periodically in search of intra-abdominal hypertension.
Discontinuation of NPWT-I was performed when the abdominal cavity was ready for fascia closure.
Fascia closure was performed when the following criteria where met:
• The source of contamination was controlled and the abdominal cavity was macroscopically clean.
• Absence of intra-abdominal hypertension.
• No clinical evidence of septic syndrome or hemodynamic instability attributable to intra-abdominal disease.
Results
In this study, 48 patients with open abdomen were treated with NPWT-I. 20 (42%) were male and 28 (58%) were female. Average age was 48 years. Causes of management via OA included: damage control surgery with contaminated abdominal cavity (n = 9), non-traumatic intra-abdominal sepsis (n = 29) and abdominal compartment syndrome with peritonitis (n = 10). Mortality in these patients was attributed to pulmonary embolism (n = 1), acute renal failure (n = 2) and cardiopulmonary arrest (n = 1). A total of 26 patients were admitted to our surgical ICU after initial evaluation, the other 22 patients were not taken to the SICU because of lack of beds, and were managed in the surgical recovery ward. Average total hospital stay was 24 days, and stay in the ICU for patients requiring aggressive monitoring (n = 26) averaged 7.5 days.
During treatment there were no acute complications related to the NPWT-I. No enteric fistulae were detected post NPWT-I. All patients presenting with abdominal compartment syndrome resolved after initiation of the NPWT-I, no patients developed intraabdominal hypertension associated with the NPWT-I. A total of 46 patients (96%) patients achieved fascia closure after NPWT-I therapy after an average of 6 days. Four patients (8%) died during the course of treatment of causes unrelated to NPWT-I. A six month follow up of all the patients revealed no further complications related to their initial episode except for 2 patients (4%) who presented with a ventral hernia which were treated in the recommended time periods [24] . Table 1 summarizes the key characteristics and outcomes of our study.
Discussion
Surgical source control in patients with severe abdominal sepsis is critical to patient survival [26] , and is especially important with the current increase in antibiotic resistance in surgical ICU patients [27] , as well as suboptimal practices related to the use of antibiotics [28] . Novel therapeutic approaches, such as NPWT-I, that allow for rapid source control without the use of drugs, appear to be valuable addition to traditional therapeutic strategies for management of contaminated abdominal cavities. The instillation and fluid retrieval, using NPWT-I device appeared to be a key element for obtaining safe and satisfactory results in the management of abdominal sepsis in our patient group. The use of normal saline appears to be sufficent in the management of complex wounds [29] , while other substances seem to be ineffective [30, 31] and exposes patients to added risks, therefore there is no clear benefit for their use in abdominal instillation [32] . Our experience with this technique initiated in 2004, and has been in use continuously, but unfortunately, the executive decree that allowed medical research to be performed in Costa Rica was repealed by constitutional resolution number 2010-001668, impeding the continuation of our study, therefore no patient data from 2009 onward was used.
In patients who required management with OA therapy under our care, the use NPWT-I showed encouraging results. Our patients had low morbidity and mortality, as well a shorter duration of stay both for the surgical ICU unit as well as the hospital. When comparing our group, to similar case studies, both in our country and abroad, we see that NPWT-I had an almost four-fold reduction in mortality [33] , a 52% increase in facial closure rates [34] a reduction of 69% in the ICU stay, and a hospital stay reduction of 57% in comparison to the use of silo closure methods [33, 34] . Even when compared to traditional NPWT, our study population showed reduced mortality (8.3% vs 23%), no intra-abdominal bleeding and lower incidence of enteric fistula [35] . We were unable to document any complications associated with this therapy in our patient group.
Due to the limited scope of our study, and scarce amount of literature available relating to the use of NPWT-I, we recommend that larger, multicenter studies be performed to validate and further explore the results associated with this approach. We recommend a control group using other methods of management of the open abdomen that may permit a more accurate comparison of the outcomes associated with each technique that due to the nature of our cohort outcome review, was not performed. Ideally the two study groups would encompass one way versus two way therapy.
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